Search Results - "HURT, Richard D"

Residential Treatment Compared With Outpatient Treatment for Tobacco Use and Dependence by Hays, J. Taylor, MD, Croghan, Ivana T., PhD, Schroeder, Darrell R., MS, Burke, Michael V., EdD, Ebbert, Jon O., MD, McFadden, David D., MD, Hurt, Richard D., MD

“…OBJECTIVE To compare the effectiveness of outpatient vs residential treatment for tobacco dependence in a large referral practice. PATIENTS AND METHODS We…”
Get full text

A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation by Hurt, Richard D, Sachs, David P.L, Glover, Penny N, Glover, Elbert D, Offord, Kenneth P, Johnston, J. Andrew, Dale, Lowell C, Khayrallah, Moise A, Schroeder, Darrell R, Sullivan, C. Rollynn, Sullivan, Pamela M, Croghan, Ivana T

“…Pharmacologic treatments such as nicotine-replacement therapy have been shown to help smokers stop smoking. Using a medication that does not contain nicotine,…”
Get full text

"Efforts to Reprioritise the Agenda" in China: British American Tobacco's Efforts to Influence Public Policy on Secondhand Smoke in China by Muggli, Monique E, Lee, Kelley, Gan, Quan, Ebbert, Jon O, Hurt, Richard D

“…Each year, 540 million Chinese are exposed to secondhand smoke (SHS), resulting in more than 100,000 deaths. Smoke-free policies have been demonstrated to…”
Get full text

Preventing Lung Cancer by Treating Tobacco Dependence by Hurt, Richard D., MD, Ebbert, Jon O., MD, Hays, J. Taylor, MD, McFadden, David D., MD

“…Tobacco use is a chronic medical disorder. Providing evidence-based treatment of tobacco-dependent patients is a challenge, and a team approach provides an…”
Get full text

Why we will never work with the tobacco industry by Hays, J. Taylor, Hurt, Richard D.

Get full text

Tobacco Use Outcomes Among Patients With Lung Cancer Treated for Nicotine Dependence by COX, Lisa Sanderson, PATTEN, Christi A, EBBERT, Jon O, DREWS, Amanda A, CROGHAN, Gary A, CLARK, Matthew M, WOLTER, Troy D, DECKER, Paul A, HURT, Richard D

“…There is a current lack of consensus about the effectiveness of nicotine dependence treatment for cancer patients. This retrospective study examined the…”
Get full text

Combination Varenicline and Bupropion SR for Tobacco-Dependence Treatment in Cigarette Smokers: A Randomized Trial by Ebbert, Jon O, Hatsukami, Dorothy K, Croghan, Ivana T, Schroeder, Darrell R, Allen, Sharon S, Hays, J. Taylor, Hurt, Richard D

“…IMPORTANCE Combining pharmacotherapies for tobacco-dependence treatment may increase smoking abstinence. OBJECTIVE To determine efficacy and safety of…”
Get full text

Association between respiratory tract diseases and secondhand smoke exposure among never smoking flight attendants: a cross-sectional survey by Ebbert, Jon O, Croghan, Ivana T, Schroeder, Darrell R, Murawski, Judith, Hurt, Richard D

“…Little is known about long-term adverse health consequences experienced by flight attendants exposed to secondhand smoke (SHS) during the time smoking was…”
Get full text

Second primary tumors following tobacco dependence treatments among head and neck cancer patients by Garces, Yolanda I, Schroeder, Darrell R, Nirelli, Liza M, Croghan, Gary A, Croghan, Ivana T, Foote, Robert L, Hurt, Richard D

“…To estimate the cumulative percentage of second primary tumors (SPTs) in head and neck (H&N) cancer patients and primary cancers in general Nicotine Dependence…”
Get full text

Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial by Hurt, Ryan T., Ebbert, Jon O., Croghan, Ivana T., Schroeder, Darrell R., Hurt, Richard D., Hays, J. Taylor

“…•Varenicline improved smoking abstinence in those with alcohol abuse or dependence.•Mean alcoholic drinks per drinking day was lower after treatment with…”
Get full text

Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace laws by Hurt, Richard D, Weston, Susan A, Ebbert, Jon O, McNallan, Sheila M, Croghan, Ivana T, Schroeder, Darrell R, Roger, Véronique L

“…Reductions in admissions for myocardial infarction (MI) have been reported in locales where smoke-free workplace laws have been implemented, but no study has…”
Get more information

Urinary Tobacco Alkaloid Measurement in Patients Having Thromboangiitis Obliterans by Hurt, Richard D., MD, Hays, J. Taylor, MD

Get full text

Nicotine Patch Therapy Based on Smoking Rate Followed by Bupropion for Prevention of Relapse to Smoking by HURT, Richard D, KROOK, James E, MORTON, Roscoe F, MICHALAK, John C, SCHAEFER, Paul L, PORTER, Patricia A, STELLA, Philip J, CROGHAN, Ivana T, LOPRINZI, Charles L, SLOAN, Jeff A, NOVOTNY, Paul J, KARDINAL, Carl G, KNOST, James A, TIRONA, Maria Tria, ADDO, Ferdinand

“…To determine whether (1) tailored nicotine patch therapy that is based on smoking rate can be carried out in a multisite oncology investigative group practice…”
Get full text

Roadmap to a tobacco epidemic: transnational tobacco companies invade Indonesia by Hurt, Richard D, Ebbert, Jon O, Achadi, Anhari, Croghan, Ivana T

“…BackgroundIndonesia is the world's fifth largest cigarette market in the world but for decades, transnational tobacco companies (TTCs) have had limited success…”
Get full text

Biochemical verification of tobacco use and cessation by Benowitz, Neal L., III, Peyton Jacob, Ahijevych, Karen, Jarvis, Martin J., Hall, Sharon, LeHouezec, Jacques, Hansson, Anna, Lichtenstein, Ed, Henningfield, Jack, Tsoh, Janice, Hurt, Richard D., Velicer, Wayne

“…The charge of our subcommittee was to assess the utility of biomarkers of tobacco use and cessation and make recommendations for their application in clinical…”
Get full text

Did We Finally Slay the Evil Dragon of Cigarette Smoking in the Late 20th Century?: Unfortunately, the Answer Is No—the Dragon Is Still Alive and Well in the 21st Century and Living in the Third World. Shame on Us by Hurt, Richard D., Murphy, Joseph G., Dunn, William F.

“…If cigarettes were introduced as a new consumer product today, it is unlikely they would receive government regulatory approval. Cigarettes have proven…”
Get full text

Combination Pharmacotherapy for Stopping Smoking: What Advantages Does it Offer? by Ebbert, Jon O., Hays, J. Taylor, Hurt, Richard D.

“…Globally, tobacco kills almost 5 million people around the world annually. Seven first-line pharmacotherapies are currently available and recommended by the…”
Get full text

Zebrafish for the Study of the Biological Effects of Nicotine by Klee, Eric W., Ebbert, Jon O., Schneider, Henning, Hurt, Richard D., Ekker, Stephen C.

“…Zebrafish are emerging as a powerful animal model for studying the molecular and physiological effects of nicotine exposure. The zebrafish have many…”
Get full text

Combination treatment with varenicline and nicotine replacement therapy by Ebbert, Jon O., Burke, Michael V., Hays, J. Taylor, Hurt, Richard D.

“…Introduction: A paucity of data exists regarding the safety and effectiveness of combination treatment with varenicline and nicotine replacement therapy (NRT)…”
Get full text

Varenicline and bupropion sustained-release combination therapy for smoking cessation by Ebbert, Jon O., Croghan, Ivana T., Sood, Amit, Schroeder, Darrell R., Hays, J. Taylor, Hurt, Richard D.

“…Introduction: Varenicline and bupropion sustained release (SR) are both safe and effective for the treatment of tobacco dependence and have different…”
Get full text